Cargando…
One-step cell biomanufacturing platform: porous gelatin microcarrier beads promote human embryonic stem cell-derived midbrain dopaminergic progenitor cell differentiation in vitro and survival after transplantation in vivo
Numerous studies have shown that cell replacement therapy can replenish lost cells and rebuild neural circuitry in animal models of Parkinson’s disease. Transplantation of midbrain dopaminergic progenitor cells is a promising treatment for Parkinson’s disease. However, transplanted cells can be inju...
Autores principales: | Feng, Lin, Li, Da, Tian, Yao, Zhao, Chengshun, Sun, Yun, Kou, Xiaolong, Wu, Jun, Wang, Liu, Gu, Qi, Li, Wei, Hao, Jie, Hu, Baoyang, Wang, Yukai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503631/ https://www.ncbi.nlm.nih.gov/pubmed/37488911 http://dx.doi.org/10.4103/1673-5374.377412 |
Ejemplares similares
-
Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells
por: Gale, Emily, et al.
Publicado: (2008) -
A protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons
por: Nishimura, Kaneyasu, et al.
Publicado: (2023) -
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
por: Drummond, Nicola J., et al.
Publicado: (2020) -
Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons
por: Nolbrant, Sara, et al.
Publicado: (2020) -
Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs
por: Liang, Lingmin, et al.
Publicado: (2022)